Organogenesis Holdings (ORGO) Revenue (QoQ) (2017 - 2026)
Organogenesis Holdings (ORGO) Revenue (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Organogenesis Holdings | 241.78 Mn | 194.94 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.53% |
| Mar 31, 2026 | -83.50% |
| Dec 31, 2025 | 49.54% |
| Sep 30, 2025 | 49.36% |
| Jun 30, 2025 | 16.51% |
| Mar 31, 2025 | -31.55% |
| Dec 31, 2024 | 9.97% |
| Sep 30, 2024 | -11.56% |
| Jun 30, 2024 | 18.42% |
| Mar 31, 2024 | 10.36% |
| Dec 31, 2023 | -8.18% |
| Sep 30, 2023 | -7.49% |
| Jun 30, 2023 | 8.99% |
| Mar 31, 2023 | -6.82% |
| Dec 31, 2022 | -1.15% |
| Sep 30, 2022 | -3.74% |
| Jun 30, 2022 | 25.00% |
| Mar 31, 2022 | -24.04% |
| Dec 31, 2021 | 12.40% |
| Sep 30, 2021 | -7.67% |